Top Markets
#1 MowCat MowCat +48.45%
#2 Bermuda Shorts Bermuda Shorts +31.49%
#3 Biconomy Biconomy +22.77%
#4 Velvet Velvet +21.04%
#5 Derive Derive +17.92%
#6 MarsCoin MarsCoin +17.75%
#7 Quack AI Quack AI +17.33%
#8 Audiera Audiera +14.23%
#9 Perle Perle +14.15%
#10 aPriori aPriori +13.82%
Coin of the day
MowCat MowCat
設定
言語
日本
通貨
USD
テーマ
Predictmedix Inc. Predictmedix Inc.

Predictmedix Inc.

PMED
株式のランク #34923
Predictmedix Inc. is an artificial intelligence firm dedicated to creating... Predictmedix Inc. is an artificial intelligence firm dedicated to creating advanced AI-driven solutions for general workplace well-being and the broader healthcare sector. Its operations are structured around two core divisions: Workplace Health and Safety, and Healthcare services. The company provides symptom screening systems designed to identify individuals with a higher probability of carrying infectious diseases, guiding them towards definitive diagnostic tests such as rapid COVID assessments. Additionally, Predictmedix develops impairment detection scanners, specialized mental health screening stations, and the Mobile Wellbeing platform, which facilitates remote patient monitoring through telemedicine. The company, formerly known as Cultivar Holdings Inc., rebranded to Predictmedix Inc. in April 2020 and is headquartered in Toronto, Canada.
株価
$0.03302716
最終同期: 2026-02-23
時価総額
$4.72M
変化（1日）
0.00%
変化（1年）
128.21%
国
CA
取引 Predictmedix Inc. (PMED)

カテゴリー

Healthcare
Predictmedix Inc.（PMED）の収益
Aug 2026 時点の収益 TTM: 0
Predictmedix Inc. の最新の財務報告によると、現在の収益 (TTM) は 0 です。2026 年には 0 の収益があり、これは 2026 年の 0 と比較して 同等 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
Predictmedix Inc. の収益履歴（2026 ～ 2026）
各年末の収益
年 収益 変化
提供された日付のデータは十分ではありません。
同業他社の収益
企業 収益 収益の差 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US